Right ventricular involvement in left ventricular non-compaction cardiomyopathy by Stämpfli, Simon F. et al.
  
ONLINE FIRST
This is a provisional PDF only. Copyedited and fully formatted version will be made available soon.
ISSN: 1897-5593
e-ISSN: 1898-018X
Right ventricular involvement in left ventricular non-
compaction cardiomyopathy
Authors:  Simon F. Stämpfli, Alexander Gotschy, Pascal Kiarostami, Tardu
Özkartal, Christiane Gruner, Markus Niemann, Robert Manka, Felix C. Tanner
DOI: 10.5603/CJ.a2020.0095
Article type: Original articles
Submitted: 2020-03-20
Accepted: 2020-06-29
Published online: 2020-07-10
This article has been peer reviewed and published immediately upon acceptance.
It is an open access article, which means that it can be downloaded, printed, and distributed freely,
provided the work is properly cited.
Articles in "Cardiology Journal" are listed in PubMed. 
Powered by TCPDF (www.tcpdf.org)
Right ventricular involvement in left ventricular non-compaction cardiomyopathy 
Running title: Right ventricular in left ventricular non-compaction 
 
Simon F. Stämpfli1, 2, *, Alexander Gotschy1, 3, *, Pascal Kiarostami1, Tardu Özkartal1, 
Christiane Gruner1, Markus Niemann1, 4, Robert Manka1, 5, Felix C. Tanner1 
1Department of Cardiology, University Heart Center Zurich, Switzerland 
2Department of Cardiology, Heart Center Lucerne, Luzerner Kantonsspital, Lucerne, 
Switzerland 
3Institute for Biomedical Engineering, University and ETH Zurich, Switzerland 
4Faculty Mechanical and Medical Engineering, Furtwangen University, Germany 
5Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Switzerland 
 
Address for correspondence: Felix C. Tanner, MD, Department of Cardiology, University 
Heart Center Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland, tel: +41 44 255 87 00, 
fax +41 44 255 87 01, e-mail: felix.tanner@usz.ch 
*Simon F. Stämpfli and Alexander Gotschy share first authorship. 
 
 
Abstract 
Background: Left ventricular non-compaction cardiomyopathy (LVNC) features extensive 
trabeculations. Involvement of the right ventricle (RV) has been reported; however, 
distinction from normal RV trabeculation is difficult. This study aimed at assessing RV 
morphology and function in LVNC by cardiac magnetic resonance (CMR) and transthoracic 
echocardiography (TTE).  
Methods: Dimensional and functional parameters were assessed according to guidelines. 
Novel CMR parameters were RV end-diastolic (ED) trabeculated area, RV ED trabeculated 
volume, and RV ED non-compacted to compacted (NC/N) ratio in short axis (SAX) as well as 
in 4-chamber view (4CH). 
Results: Twenty patients with LVNC and twenty controls were included. RV size and 
function were comparable in LVNC and controls and exhibited a good correlation between 
TTE and CMR. Although RV trabeculated area, RV trabeculated volume, and RV ED NC/C 
ratio in SAX as well as in 4CH were larger in LVNC, there was a major overlap with values 
in controls. RV ED NC/C ratio in SAX correlated with LV ED NC/C ratio (not in 4CH). 
Quantitative assessment of RV non-compaction was not feasible in TTE. 
Conclusions: Right ventricle size and function in LVNC can be measured by CMR and TTE, 
while RV trabeculation can only be quantified by CMR. RV myocardium displays more 
trabeculations in LVNC; however, overlap with normal individuals is extensive, not allowing 
separation of patients with LVNC from controls. 
Key words: trabeculation, cardiac magnetic resonance imaging, echocardiography, left 
ventricular non-compaction cardiomyopathy 
 
 
Introduction 
Left ventricular non-compaction cardiomyopathy (LVNC) is characterized by a two-
layered myocardium involving a thin, compacted, outer layer and a thick, non-compacted, 
inner layer with deep recesses between prominent trabeculations [1]. During recent years, the 
awareness of LVNC has increased [2–6], with wider recognition of the disease and systematic 
family screening, the number of symptomatic and asymptomatic patients diagnosed with 
LVNC is growing [7–14].  
While most studies have focused on the left ventricle (LV) [15–17], prominent 
trabeculation has also been reported in the right ventricle (RV) of patients with LVNC [5, 18, 
19]. In addition, RV systolic function was decreased in patients with advanced LVNC and 
seemed to be associated with impaired outcome [20–22]. However, the extent and incidence 
of RV involvement remains unclear. Cardiac magnetic resonance (CMR) performed in 56 
LVNC patients revealed in only 6 patients RV non-compaction as defined somewhat 
arbitrarily by the presence of recesses within the inflow area of the RV involving at least 75% 
of the RV thickness [21]. RV apical trabecular thickness assessed by CMR correlated with the 
extent of LV involvement in LVNC, whereas RV end-diastolic (ED) non-compacted to 
compacted (NC/C) ratio in four-chamber view (4CH) did not differ from normal ventricles 
[22]. RV systolic function was decreased in patients with advanced LVNC and seemed to be 
associated with enhanced RV trabeculation and impaired outcome [20–23].  
Due to its complex shape, comprehensive evaluation of the RV is difficult by 
transthoracic two-dimensional echocardiography (TTE) [20]. In addition, the RV exhibits a 
substantially higher number of trabeculations than the LV even in healthy individuals, 
wherefore it is challenging to differentiate between normal and pathologic anatomy in patients 
with suspected LVNC [22]. CMR provides a full volume three-dimensional (3D) dataset 
independent of acoustic windows and is regarded as the reference method for assessing the 
RV in various cardiac diseases [24]. It is of great value for diagnosis and morphological 
description of LVNC in the LV and indeed has become one of the standard modalities for 
assessing LVNC patients [25–28]. On the other hand, due to its wide availability and high 
versatility, echocardiography is still the standard tool for assessment of LV and RV in patients 
with cardiomyopathies. 
Neither the optimal imaging modality nor standardized measurements for RV 
assessment in LVNC patients have been defined. This study aims at assessing RV 
morphology in LVNC patients versus controls by introducing novel CMR parameters such as 
trabeculated area, trabeculated volume, and NC/C ratio in short axis and at comparing the 
suitability of CMR and TTE for diagnosing RV involvement in LVNC patients. 
 
Methods 
Twenty patients with LVNC (fulfilling both TTE [15] and CMR criteria [27]) and 20 
healthy controls (age and gender matched) underwent TTE and CMR at the University 
Hospital Zurich between 2011 and 2016. Measurements were performed in a blinded manner. 
Patient records were reviewed for baseline characteristics, New York Heart Association 
(NYHA) functional class, body height, body weight, blood pressure, heart rate, and 
medication. The study was approved by the local ethical committee. 
All CMR exams were performed on a clinical 1.5 T scanner (Achieva, Philips 
Healthcare, Best, The Netherlands) using a 5-channel cardiac coil array. Steady-state free 
precession cine images (echo time/repetition time 1.6/3.3 ms, flip angle 60°) were acquired in 
three long-axis views (2-, 3-, and 4-chamber view) and a stack of short-axis slices covering 
the whole LV and RV. A single reader performed all CMR analysis in a blinded manner using 
GTVolume software (GyroTools LLC, Zurich, Switzerland). Commonly measured 
dimensional and functional parameters were assessed according to current guidelines and 
recommendations [29, 30]. As novel CMR parameters RV end-diastolic (ED) trabeculated 
area in 4CH view, RV ED trabeculated volume, and RV ED non-compacted to compacted 
ratio in short axis (SAX) and long axis (LAX) were introduced (Fig. 1A–E). RV ED 
trabeculated area was quantified by manually contouring the trabeculation in 4CH view, while 
RV ED trabeculated volume was assessed by summation of the trabeculated area in all RV 
short axes multiplied by the slice thickness. RV ED NC/C values in long and short axis are 
reported as the maximal ratio of the thickness of NC to C layer measured at a single location 
perpendicular to the compacted wall. 
Echocardiographic studies were performed on commercially available 
echocardiography units (GE E95 and E9, GE Healthcare, Horten, Norway and Philips iE33 
and Epic, Philips Medical Systems, Erlangen, Germany) equipped with multi-frequency 
transducers (1.5–4 MHz). All examinations were performed by experienced sonographers and 
stored on a digital workstation for subsequent off-line analysis (Xcelera R4.1, Philips Medical 
Systems, Erlangen, Germany). A modified apical 4CH view focusing on the RV was used to 
measure RV area and fractional area change (FAC) by tracing the endocardial surface of the 
RV compacted myocardial layer both in systole and diastole [31]. Commonly measured 
dimensional and functional parameters were assessed according to current guidelines and 
recommendations [32]. 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism (Version 5.04, La Jolla, 
USA). Normal distribution of data was confirmed using the Shapiro-Wilk test. Normally 
distributed continuous values are depicted as mean ± standard deviation (SD), non-normally 
distributed continuous data as median and interquartile range (IQR). Categorical data is 
displayed as number (percentage). To determine the statistical significance between LVNC 
and control group, the unpaired Student t-test was used. The agreement between CMR and 
echocardiography measurements was assessed with the Spearman rank correlation. A p-value 
< 0.05 was considered statistically significant. 
 
Results 
Twenty patients (9 females, 45%) with confirmed LVNC and 20 healthy subjects (7 
females, 35%) were included in the study. The median age of patients with LVNC at the time 
of CMR was 46 (IQR 33–57) years, that of controls was 54 (IQR 43–57) years (p = 0.16). In 
29 subjects, TTE and CMR took place on the same day; in the remaining 11 subjects, the 
median time between the two examinations was 11 (4–40) days. CMR-based LV ejection 
fraction (LVEF) was lower in LVNC patients as compared to controls (52% vs. 62%, p < 
0.0001). However, median LVEF in LVNC patients was only mildly impaired (median 53%, 
IQR 48–57%); 8 (40%) patients had a normal LVEF (≥ 55%). Heart rate was slightly higher 
and systolic blood pressure lower in LVNC patients as compared to controls. Table 1 
summarizes baseline characteristics. 
RV ED area exhibited good correlation between TTE and CMR (Fig. 2, absolute 
values Table 2) in LVNC (r = 0.66, β = 0.85, p = 0.0016) and in controls (r = 0.88, β = 0.80, p 
< 0.0001). RV ED area was higher in CMR as compared to TTE for LVNC (agreement of 
ΔCMR-TTE = 7.5 cm2, 95% limits of agreement 0.007–15.1) and for controls (agreement of 
ΔCMR-TTE = 7.8 cm2, 95% limits of agreement 1.8–13.7). Similarly, RV ED basal diameter 
was higher in CMR as compared to TTE for both groups (LVNC: agreement of ΔCMR-TTE 
= 7.9 mm, 95% limits of agreement –2.5–18.4; controls: agreement of ΔCMR-TTE = 9.7 mm, 
95% limits of agreement –0.9–20.1).  
Fractional area change was assessed as a functional parameter and exhibited good 
correlation between the two imaging modalities in LVNC (r = 0.72, β = 0.92, p = 0.0004) and 
in controls (r = 0.56, β = 0.65, p = 0.011). The bias between the two methods was minimal in 
LVNC (agreement of ΔCMR-TTE = 3.3%, 95% limits of agreement –12.1–18.7) and in 
controls (agreement of ΔCMR-TTE = 1.1%, 95% limits of agreement –9.79–11.93). 
In TTE, quantitative assessment of RV non-compaction was not feasible. In particular, 
the decline of lateral resolution with imaging depth hampered a reliable quantification of RV 
trabeculated area and RV NC/C ratio along the whole RV free wall. In addition, reverberation 
artifacts as well as near field artifacts accounted for an inadequate quantification of RV 
trabeculation. 
The data comparing RV parameters in LVNC and controls are summarized in Tables 2 
and 3. RV size was assessed by RV ED area and RV ED basal diameter, while RV systolic 
function was determined by FAC. All these parameters were comparable in LVNC and 
controls, and this finding was observed with both imaging modalities (Fig. 2). In contrast, RV 
ED trabeculated area in 4CH view and RV ED trabeculated volume were significantly higher 
in LVNC as compared to controls (Table 3, Fig. 3A, B). There was a major overlap of values 
obtained in patients and controls. Only 6 (30%) patients displayed values above the upper 
limit of normal for both parameters (mean+2SD; 12.4 cm2 for area; 50.9 mL for volume). 
Similarly, RV ED NC/C ratio in SAX and RV ED NC/C ratio in 4CH were significantly 
higher in LVNC than in controls (Table 3, Fig. 4A, B), but with a major overlap between the 
two groups. Six (30%) patients displayed values above the upper limit of normal for NC/C in 
SAX (4.74), and only 4 (20%) patients displayed values above the upper limit of normal for 
NC/C in 4CH (4.22). RV ED NC/C ratio in SAX as well as RV ED NC/C ratio in 4CH 
correlated with LV ED NC/C ratio in long axis (SAX: r = 0.61, β = 0.60, p = 0.0044, Fig. 4C; 
4CH: r = 0.77, β = 0.70, p = 0.0001, Fig. 4D). No significant correlation was observed for 
RVEF and RV ED NC/C ratio, neither in 4CH nor in SAX (r = –0.104, β = 0.21, p = 0.66). 
 
Discussion 
This study assessed RV morphology, size, and function in LVNC patients and controls 
using two different imaging modalities (CMR and TTE). RV size and function were 
comparable in LVNC patients and controls by use of both modalities. Parameters indicating 
right ventricular involvement in LVNC such as RV ED trabeculated area and volume 
measured by CMR were significantly higher in the LVNC group although there was a major 
overlap between RV trabeculation of LVNC patients and controls hampering diagnosis of RV 
involvement in LVNC. 
While several studies have compared CMR and TTE in LVNC patients regarding the 
LV [25, 26], this is the first study to do so for RV parameters. Assessment of RV size 
exhibited good correlation between the two imaging modalities. Dimensional parameters such 
as RV ED area and RV ED basal diameter exhibited higher values in CMR as compared to 
TTE. This is in line with the current guidelines reporting higher values for these parameters in 
CMR [33, 34] as compared to TTE [32]. RV systolic function assessed by FAC exhibited 
good correlation between the two imaging modalities. In contrast to the afore-mentioned 
dimensional parameters, the values for FAC were very similar with both methods presumably 
because dimensional parameters are considered in a relative manner when a fraction such as 
FAC is calculated. 
To assess the extent of non-compaction in the RV myocardium, different parameters 
were measured such as trabeculated area, trabeculated volume, and NC/C ratio in long and 
short axis. While RV ED NC/C ratio in long axis has been measured in a previous study [22], 
the other parameters have not been investigated yet in LVNC patients. In contrast to CMR, it 
was not feasible to assess the extent of non-compaction in the RV myocardium by TTE for 
different reasons. First, there is no controllable echocardiographic equivalent to the CMR 
short axis with whole heart coverage to calculate RV trabeculated volume. In theory, this is 
feasible in a 3D echocardiography data set; however, current technology does not provide 
sufficient spatial solution to reliably assess NC/C ratio. Second, the decline of lateral 
resolution with imaging depth, reverberations, and near field artifacts in combination with 
suboptimal acoustic windows in a subset of patients hampered the accurate quantification of 
RV trabeculated area and RV ED NC/C-ratio. 
Cardiac magnetic resonance imaging and TTE displayed similar RV size and function 
in LVNC as compared to controls. This seems to be in contrast to a previous study describing 
impaired RV function in LVNC [22]. In the cited study, however, LVNC patients were at a 
later stage of the disease as indicted by higher age, lower LVEF, and higher rate of heart 
failure. In line with this, studies examining RV function in LVNC patients revealed an 
association of RV dysfunction with LV dysfunction as well as with heart failure symptoms 
[20, 21].  
To assess RV non-compaction in LVNC, the afore-mentioned novel parameters were 
determined. RV ED trabeculated area and RV ED trabeculated volume were higher in LVNC 
as compared to controls. Similarly, RV ED NC/C ratio in both long and short axis was 
increased in LVNC as compared to controls. However, it is questionable whether these 
differences represent an RV involvement since there was a major overlap with 70% of LVNC 
patients within the normal range. This is partially in line with another cohort of LVNC 
patients, where RV ED NC/C ratio in long axis was not increased as compared to a control 
group [22]. 
RV ED NC/C ratio in SAX and 4CH correlated significantly with the extent of LV 
non-compaction as assessed by a standardized protocol [27]. Similar to these results, another 
study described that apical trabecular thickness in the RV correlates with LV end-systolic 
NC/C ratio [22]. To exclude that the correlation was only due to the one patient with much 
higher NC/C ratios, the analysis was repeated without this patient. In the latter analysis, the 
correlation was still significant when RV ED NC/C ratio was measured in SAX while it was 
not significant thereafter when measured in 4CH. The reason for the more robust correlation 
with the SAX method may be related to the observation that RV NC/C SAX displays the 
maximal NC/C ratio of all RV segments (as CMR SAX covers the whole RV). In contrast, 
RV NC/C in 4CH only covers a small part of the RV free wall, which may not be 
representative for the whole RV.  
The present findings suggest that (1) the RV may be affected in some patients with 
LVNC and that (2) RV ED NC/C ratio measured in short axis is a more reliable parameter for 
evaluating RV involvement than RV ED NC/C ratio measured in long axis. However, for all 
parameters of RV non-compaction determined in this study, there is a major overlap between 
LVNC and controls, which seems to be related to the prominent trabeculation of the RV in 
normal individuals, and which renders the diagnosis of RV involvement in LVNC patients 
very difficult. It is almost impossible to define a diagnostic cutoff value for RV trabeculation 
with only 30% of LVNC patients above the upper limit of normal. 
Interestingly, also for LV morphology, a recent study on the current CMR criteria for 
the diagnosis of LVNC describes a high variability and their prognostic value seems 
questionable [14]. This and the present findings suggest that a more comprehensive approach 
including LV and RV morphology as well as genetic and functional parameters may increase 
diagnostic accuracy. Further studies will be needed to examine this hypothesis. 
Cardiac magnetic resonance imaging and TTE provide similar quantitative data on RV 
size and function in LVNC patients suggesting that these parameters can be assessed by TTE 
in clinical routine, resulting in lower cost and avoiding problems related to implantable 
cardioverter-defibrillator and claustrophobia. In contrast, CMR is the method of choice for 
morphological assessment of RV trabeculations.  
A limitation of this study is that LVNC is a very rare disease, accounting for the small 
number of patients. In addition, referral bias may have affected the results. 
 
Conclusions 
Some patients with LVNC may exhibit non-compaction of the RV myocardium with 
higher values for RV trabeculated area, RV trabeculated volume, and RV NC/C ratio as 
compared to control individuals. Consistent with this, the NC/C ratio exhibited a fair 
correlation between RV and LV. Nevertheless, there is substantial overlap with RV 
trabeculation in healthy individuals. Thus, quantification of RV trabeculation does not allow 
separation of LVNC form healthy individuals. Even though measurement of RV trabeculation 
may not serve as an independent diagnostic tool, it was thought, herein, that it improves the 
evaluation of LVNC patients. In the future it may serve as an additional parameter in 
comprehensive diagnostic and prognostic approaches possibly including LV and RV 
morphology as well as genetic and functional parameters. 
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Figure 1. Example of right ventricular end-diastolic non-compacted to compacted ratio as 
assessed in short axis view (A), right ventricular end-diastolic trabeculated area assessed in 
four-chamber view (B), and right ventricular end-diastolic trabeculated volume as assessed in 
short-axis views on a basal (C), midventricular (D) and apical level (E). 
Figure 2. Right ventricular end-diastolic area as measured in transthoracic echocardiography 
(TTE) and cardiac magnetic resonance (CMR) exhibits good correlation between the two 
methods in both left ventricular non-compaction cardiomyopathy (LVNC) patients and 
controls. Scatter plot correlation graph (left), Bland-Altman plot (right). 
Figure 3. End-diastolic trabeculated area (A) and end-diastolic trabeculated volume (B) as 
assessed in cardiac magnetic resonance (CMR) in left ventricular non-compaction 
cardiomyopathy (LVNC) patients as compared to controls. Lines represent median values. 
Upper and lower limit of normal (grey): 6 (30%) patients are above the upper limit for both 
parameters. 
Figure 4. Right ventricular end-diastolic non-compacted to compacted ratio as assessed in 
cardiac magnetic resonance (CMR) short axis view (A) and in CMR four-chamber view (B) 
in left ventricular non-compaction cardiomyopathy (LVNC) patients as compared to controls. 
Lines represent median values. Upper and lower limit of normal (grey): 6 (30%) patients are 
above the upper limit of non-compacted to compacted (NC/C) ratio in short axis (SAX), 4 
(20%) patients above the upper limit of NC/C ratio in four-chamber view (4CH). Right 
ventricular end-diastolic NC/C ratio as assessed in CMR short axis view (C) as well as when 
assessed in CMR 4CH (D) exhibits significant correlation with conventional left ventricular 
end-diastolic NC/C ratio as assessed in CMR 4CH. 
 
Table 1. Patient characteristics. 
Characteristic 
LVNC 
 (n = 20) 
Controls 
(n = 20) 
P 
Age [years] 46 (33–57) 54 (43–57) 0.16 
Female sex  9 (45%) 7 (35%) 0.52 
Body mass index [kg/m2] 24.3 ± 4.0 26.2 ± 4.6 0.09 
Heart rate [bpm] 65.5 ± 11.6 64.8 ± 13.1 0.6 
Systolic blood pressure [mmHg] 117 ± 13.4 131 ± 9.7 0.03 
Diastolic blood pressure [mmHg] 71.0 ± 8.5 78.6 ± 8.8 0.07 
NYHA class:    
 Class I 17 (85%) 20 (100%)  
 Class II 3 (15%) 0 (0%)  
Left ventricular ejection fraction (CMR) [%] 51.6 ± 8.6 62.0 ± 4.3 < 0.0001 
Medication:    
 Acetylsalicylic acid 1 (5%) 0 (0%)  
 Phenprocoumon 3 (15%) 0 (0%)  
 Beta-blocker 5 (25%) 0 (0%)  
 ACEI or ARB 8 (40%) 0 (0%)  
 Diuretics 6 (30%) 0 (0%)  
Data are shown as mean ± standard deviation or median (interquartile range) or number (percentage). ACEI — angiotensin-converting enzyme inhibitor; ARB — angiotensin-
receptor blocker; CMR — cardiac magnetic resonance imaging; LVNC — left ventricular non-compaction cardiomyopathy; NYHA — New York Heart Association 
 
 
 
Table 2. Structural and functional right ventricular parameters in transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging 
(CMR). 
Parameter 
LVNC 
(n = 20) 
Controls 
(n = 20) 
P 
RV ED area [cm2]    
 CMR 25.3 (23.2–33.3) 28.0 (25.0–31.2) 0.86 
 TTE 18.1 (15.3–25.2) 20.4 (17.9–22.5) 0.96 
RV ED basal diameter [mm]:    
 CMR 36 (30–41) 41 (37–44) 0.18 
 TTE 28 (25–32) 30 (27–32) 0.4 
FAC [%]:    
 CMR 46.3 ± 11.8 42.8 ± 6.2 0.25 
 TTE 43.0 ± 9.6 41.8 ± 5.0 0.62 
Data are shown as mean ± standard deviation or median (interquartile range). ED — end-diastolic; FAC — fractional area change; LVNC — left ventricular non-compaction 
cardiomyopathy; NC/C — non-compacted to compacted; RV — right ventricle; SAX — short axis 
 
 
Table 3. Quantitative assessment of right ventricle (RV) non-compaction in cardiac magnetic resonance imaging (CMR). 
Parameter 
LVNC 
(n = 20) 
Controls 
(n = 20) 
P 
RV ED trabeculated area [cm2] 9.15 ± 3.69 6.47 ± 2.97 0.048 
RV ED trabeculated volume [mL] 35.2 (25.6–61.3) 27.0 (19.5–35.2) 0.028 
RV ED NC/C ratio in SAX  3.93 (3.39–5.18) 2.96 (2.48–3.69) 0.001 
RV ED NC/C ratio in 4CH  3.3 (2.94–4.13) 2.73 (2.00–3.10) 0.019 
Data are shown as mean ± standard deviation or median (interquartile range). ED — end-diastolic; LVNC — left ventricular non-compaction cardiomyopathy; NC/C — non-
compacted to compacted; SAX — short axis; 4CH — four-chamber view 
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